Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification.
Bagan
Jose V
JV
Jimenez
Yolanda
Y
Diaz
Jose M
JM
Murillo
Judith
J
Sanchis
Jose M
JM
Poveda
Rafael
R
Carbonell
Enrique
E
Gavalda
Carmen
C
Scully
Crispian
C
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced / Q000145:classification / Q000628:therapy*; D010020:Osteonecrosis / Q000139:chemically induced / Q000145:classification / Q000628:therapy*; D017410:Practice Guidelines as Topic
D050071:Bone Density Conservation Agents; D004164:Diphosphonates